A clear experience for more people.

Rejuvonix is being built toward WCAG 2.2 Level AA accessibility across the public website and simulated member journey.

Current design practices

The site includes keyboard-accessible controls, visible focus treatment, descriptive labels, progress information that is not color-only, reduced-motion support and responsive layouts.

Work still in progress

Final browser, screen-reader, high-contrast, 200% zoom, mobile orientation and end-to-end keyboard testing remain required before production clinical use.

Need assistance?

Email info@rejuvonix.com to report a website accessibility problem. Do not include medical information in ordinary email. If another accessible method is needed after clinical services launch, support will help coordinate an approved alternative.